Adrenocortical oncocytoma manifesting as primary aldosteronism: a case report.

Blood PressJul 22, 2026 (epub)

Qun Ji, Yikai Liu, Yuhai Zhang et al.

✦ AI-curated · Sources linked

Case in brief

A 44-year-old man presented with severe hypertension and hypokalaemia, revealing a right adrenal lesion on imaging. Evaluation confirmed primary aldosteronism, with adrenal venous sampling indicating right-sided aldosterone secretion. Following laparoscopic right adrenalectomy, histopathology identified an adrenocortical oncocytoma. The patient experienced biochemical correction and clinical improvement, with positive outcomes at 19-month follow-up.

What made this case unusual

This case highlights an adrenocortical oncocytoma presenting as primary aldosteronism, a notably rare occurrence, as most oncocytomas are non-functioning.

Diagnostic / clinical pearl

Clinicians should consider adrenocortical oncocytoma in patients with primary aldosteronism, especially when typical imaging and biochemical evaluations are present.

Why it matters

Understanding the potential for oncocytomas to secrete aldosterone expands the differential diagnosis for primary aldosteronism and underscores the importance of surgical intervention.

Source

Published in Blood Press. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.